In a major deal for the off-patent industry, Sandoz recently announced a multi-year collaboration with Evotec subsidiary Just-Evotec Biologics that will see the firms develop and manufacture multiple biosimilars together.
The alliance – which Sandoz’s biosimilars head saidwould be “a game-changer” for the firm’s biopharma business (Also see "Slovenia...